The chemical and pharmacological importance of morphine analogues

Acta Physiologica Hungarica

Volumn 95, Issue 1, 2008, Pages 3-44

  Furst S ^a   Hosztafi, S ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Mixed agonist antagonists; Morphine; Opioid analgesics; Opioid antagonists; Partial agonists; Structure activity relationships

Indexed keywords

MORPHINE DERIVATIVE; NARCOTIC AGENT; NARCOTIC ANALGESIC AGENT;

ARTICLE; CHEMISTRY; DRUG DESIGN; HUMAN; MORPHINE ADDICTION; PAIN; PATHOPHYSIOLOGY; STRUCTURE ACTIVITY RELATION;

ANALGESICS, OPIOID; DRUG DESIGN; HUMANS; MORPHINE DEPENDENCE; MORPHINE DERIVATIVES; NARCOTICS; PAIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 40049091425     PISSN: 0231424X     EISSN: 15882683     Source Type: Journal    
DOI: 10.1556/APhysiol.95.2008.1.1     Document Type: Article

References (108)

1. Albertson NF (1974): Cyclazocine and congeners. In: Narcotic Antagonists, eds: Braude MC, Harris LS, May EL, Smith JP, Villareal JE, Advances in Biochem. Psychopharmacol. Vol. 8. Raven Press, New York, pp. 63-79
2. Archer S, Albertson NF, Harris LS, Pierson AK, Bird JG: Pentazocine, strong analgesics and analgesic antagonists in the benzomorphan series. J. Med. Chem. 7, 123-127 (1964)
3. Archer S, Harris LS: Narcotic antagonists. Progress in Drug Res. 8, 261-320 (1965)
4. Archer S, Michne WF: Recent progress in research on narcotic antagonists. Progress in Drug Res. 20, 45-100 (1976)
5. Archer S, Glick SD, Bidlack JM: Cyclazocine revisited. Neurochem. Res. 21, 1369-1373 (1996)
6. Beckett AH, Casy AF: The testing and development of analgesic drugs. Progress in Med. Chem. 2, 43-87 (1962)
7. Beckett AH, Casy AF: Analgesics and their antagonists. Biochemical aspects and structure-activity relationships. Progress in Med. Chem. 4, 171-218 (1965)
8. Bentley KW (1971): The morphine alkaloids. In: The Alkaloids Chemistry and Physiology, Vol. 13, ed. Manske RHF, Academic Press, New York and London, pp. 1-163
9. Bentley KW, Lewis JW (1972): The relationship between structure and activity in the 6,14-endoethenotetrahydrothebaine series of analgesics. In: Agonist and Antagonist Actions of Narcotic Analgesic Drugs, eds Kosterlitz HW, Collier HOJ, Villareal JE, University Park Press, Baltimore, London, Tokyo, pp. 7-16
10. Blumberg H, Dayton HB (1974): Naloxone, naltrexone and related noroxymorphones. In: Narcotic Antagonists, eds Braude MC, Harris LS, May EL, Smith JP, Villareal JE, Advances in Biochem. Psychopharmacol. Vol. 8, Raven Press, New York, pp. 33-43
11. Braenden OJ, Eddy NB, Halbach H: Synthetic substances with morphine-like effect. Relationship between chemical structure and analgesic action. Bull. World Health Org. 13, 937-998 (1955)
12. Brossi A (1985): The chemistry and pharmacology of morphinan alkaloids. In: The Chemistry and Biology of Isoquinoline Alkaloids, eds Philipson JD, Roberts MF, Zenk MH, Springer-Verlag, Berlin, Heidelberg, pp. 171-190
13. Brossi A, Atwell L, Jacobson AE, Rozwadowska M, Schmidhammer H, Flippen-Anderson J, Gilardi R: Structure-activity relationship of oxygenated morphinans. VII. 5-Methylated and 14-hydroxy-substituted agonists and antagonists of the 4-hydroxy- and 3,4-dioxygenated 6-morphinanone series. Helv. Chim. Acta 65, 2394-2404 (1982)
14. Buckett WR, Farquharson ME, Haining CG: The analgesic properties of some 14-substituted derivatives of codeine and codeinone. J. Pharm. Pharmacol. 16, 174-182 (1964)
15. Casy AF: Analgesics and their antagonists. Recent developments. Progress in Med. Chem. 7,229-284 (1970)
16. Casy AF: Analgesics and their antagonists. Recent developments. Progress in Drug Research 22, 149-227 (1978)
17. Casy AF: Opioid receptors and their ligands. Recent developments. Advances in Drug Research 18, 177-289 (1989)
18. Casy AF, Parfitt RT (1986): Opioid Analgesics Chemistry and Receptors. Plenum Press, New York, 518 pages
19. Chatterije N, Inturrisi CE, Dayton HB, Blumberg H: Stereospecific synthesis of the 6-beta-hydroxy metabolites of naltrexone and naloxone. J. Med. Chem. 18, 490-492 (1975)
20. Chen ZR, Irvine RJ, Bochner F, Somogyi AA: Morphine formation from codeine in rat brain: a possible mechanism of codeine analgesia. Life Sci. 46, 1067-1074 (1990)
21. Cherny NI: Opioid analgesics. Comparative features and prescribing guidelines. Drugs 51, 713-737 (1996)
22. Clark RL, Pessolano AA, Weijlard J, Pfister K: N-substituted epoxymorphinans. J. Am. Chem. Soc. 75, 4963-4967 (1953)
23. Davids E, Gastpar M: Buprenorphine in the treatment of opioid dependence. Eur. Neuropharmacol. 14, 209-216 (2004)
24. Eddy NB, Halbach H, Braenden OJ: Synthetic substances with morphine-like effect. Relationship between analgesic action and addiction liability, with a discussion of chemical structure of addiction-producing substances. Bull. World Health Org. 14, 353-402 (1956)
25. Eddy NB, Besendorf H, Pellmont B: Synthetic analgesics. Aralkyl substitution on nitrogen of morphinan. Bull. Narcotics 10(4), 23-42 (1958)
26. Eddy NB (1959): Chemical structure and action of morphine-like analgesics and related substances. Chem. & Ind. 1462-1469
27. Eddy NB, May EL: The search for a better analgesic. Science 181, 407-414 (1973)
28. Eliel EL, Morris-Natschke S, Kolb VM: Conformational analogies of morphine agonists and antagonists as revealed by carbon-13 spectroscopy. Org. Magn. Reson, 22, 258-262 (1984)
29. Findlay JW: Pholcodine. J. Clin. Pharm. Ther. 13, 5-17 (1988)
30. Friedmann T, Toth Z, Hosztafi S, Simon C, Makleit S, Furst S: Influence of spatial orientation of the c-6-oh group in ring c of morphine derivatives on opioid activity. Arch. Intern. Pharmacodyn. Ther. 328, 16-25 (1994)
31. Furst S, Hosztafi S, Friedmann T: Structure-activity relationships of synthetic and semisynthetic opioid agonists and antagonists. Curr. Med. Chem. 1, 423-440 (1995)
32. Gates M, Montzka T: Some potent morphine antagonists possessing high analgesic activity. J. Med. Chem. 7, 127-131 (1964)
33. Gates M, Boden RM, Sundaraman P: Derivatives of the thebaine anion. 2. 5-Methylmorphine, 5-methylcodeine, 5-methylheroin and some related compounds. J. Org. Chem. 54, 972-974 (1989)
34. Ghozland F, Maroni P, Viloria I, Cros J: 8-Alkyldihydrocodeinones and dihydromorphinones: Analgesic activity and affinity for opiate receptors. Eur. J. Med. Chem. 18, 22-26 (1983)
35. Gonzalez JP, Brogden RN: Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs 35, 192-213 (1988)
36. Green AF, Ruffell GK, Walton E: Morphine derivatives with antianalgesic action. J. Pharm. Pharmacol. 6, 390-397 (1954)
37. Gutstein HB, Akil H (2001): Opioid analgesics. In: Goodman and Gilman's: The Pharmacological Basis of Therapeutics. McGraw-Hill, New York, 10th Edition, pp. 569-621
38. Hahn EF: Opiate agonists and antagonists. Drugs of the Future 9, 443-459 (1984)
39. Hashimoto A, Jacobson AE, Rothman RB, Dersch CM, George C, Flippen-Anderson JL, Rice KC: Probes for narcotic receptor mediated phenomena. Part 28. New opioid antagonists from enatiomeric analogues of 5-(3-hydroxyphenyl)-N-phenylethylmorphan. Bioorg. Med. Chem. 10, 3319-3320 (2002)
40. Herlihy H, Dalzell HC, Howes JF, Razdan RK: Novel opiates and antagonists. 5. 7-Carbethoxy-N-(cycloalkylmethyl)-3-hydroxymorphinan-6-ones and -isomorphinan-6-ones. J. Med. Chem. 25, 986-990 (1982)
41. Hirano T, Oguri K, Yoshimura H: Synthesis and pharmacological activity of sulfate conjugates at 6-position of N-substituted normorphine derivatives. Chem. Pharm. Bull. 39, 2000-2004 (1991)
42. Hoskin PJ, Hanks GW: Opioid agonist-antagonist drugs in acute and chronic pain states. Drugs 41, 326-344 (1991)
43. Isbell H: The search for a nonaddicting analgesic: has it been worth it? Clin. Pharmacol. Ther. 22, 377-384 (1977)
44. Jacobson AE, Hsu F, Rozwadowska M, Schmidhammer H, Atwell L, Brossi A, Medzihradsky F: Structure-activity relationships of oxygenated morphinans. 1. 4-Monomethoxy-N-methylmorphinans and 3,4-dimethoxy-N-methyl-morphinan-6-ones with unusually high antinociceptive potency. Helv. Chim. Acta 64, 1298-1302 (1981)
45. Kalso E: Oxycodone. J. Pain Symptom Manag. 29 (5S) S47-S56 (2005)
46. Kanematsu K, Takeda M, Jacobson AE, May EL: Synthesis of 6,7-benzomorphan and related nonquaternary carbon structures with marked analgetic activity. J. Med. Chem. 12, 405-408 (1969)
47. King MA, Su W, Nielan CL, Chang AH, Schutz J, Schmidhammer H, Pasternak GW: 14-Methoxymetopon a very potent μ-opioid receptor-selective analgesic with an unusual pharmacological profile. Eur. J. Pharmacol. 459, 203-209 (2003)
48. Knoll J, Fürst S, Kelemen K: The pharmacology of azidomorphine and azidocodeine. J. Pharm. Pharmacol. 25, 929-935 (1973)
49. Knoll J, Fürst S, Makleit S: The pharmacology of 14-hydroxyazidomorphine. J. Pharm. Pharmacol. 27, 99-105 (1975)
50. Knoll J: Predictive values of pharmacological models to study opiate dependence. Neuropharmacology 14, 921-926 (1975)
51. Kobylecki RJ, Carling RW, Lord JAH, Smith CFC, Lane AC: Common anionic receptor site hypothesis: its relevance to the antagonist action of naloxone. J. Med. Chem. 25, 116-120 (1982)
52. Kosterlitz HW, Waterfield AA: In vitro models in the study of structure-activity relationships of narcotic analgesics. Annual Rev. Pharmacol. 15, 29-47 (1975)
53. Kotick MP, Leland DL, Polazzi JO, Schut RN: Analgesic narcotic antagonists. 1. 8-β-Alkyl, 8-β-acyl and 8-β-tertiary alcohol-dihydrocodeinones and dihydromorphinones. J. Med. Chem. 23, 166-174 (1980)
54. Kotick MP: 7-β-8-β-Methano- and 7-β-8-β- epoxydihydrocodeinone. J. Med. Chem. 24, 722-726 (1981)
55. Kotick MP, Leland DL, Polazzi JO, Howes JF, Bousquet AR: Analgesic narcotic antagonists. 8. 7 α-Alkyl-4,5 α-epoxymorphinan-6-ones. J. Med. Chem. 24, 1445-1450 (1981)
56. Lewis JW, Bentley KW, Cowan A: Narcotic analgesics and antagonists. Annual Rev. Pharmacol. 11, 241-270 (1971)
57. Lewis JW (1974): Ring C-bridged derivatives of thebaine and oripavine. In: Narcotic Antagonists, eds Braude MC, Harris LS, May EL, Smith JP, Villareal JE, Advances in Biochem. Psychopharmacol. Vol. 8, Raven Press, New York, pp. 123-136
58. Lewis JW: Buprenorphine. Drug and Alcohol Depend. 14, 363-372 (1985)
59. Lewis JW, Husbands SM: The orvinols and related opioids - high affinity ligands with diverse efficacy profiles. Curr. Pharm. Design 10, 717-732 (2004)
60. Lousberg RJ, Weiss U: The analgesic action of 1-fluorocodeine. Experientia 30, 1440-1441 (1974)
61. Manmade A, Dalzell HC, Howes JF, Razdan RK: (-)-4-Hydroxymorphinanones: their synthesis and analgesic activity. J. Med. Chem. 24, 1437-1440 (1981)
62. Martin WR: Opioid antagonists. Pharmacol. Reviews 19, 463-521 (1967)
63. Martin WR: Pharmacology of Opioids. Pharmacol. Reviews 35, 283-323 (1983)
64. May EL: Third Smissman Award address: reminiscences and musings of a classical medicinal chemist. J. Med. Chem. 23, 225-232 (1980)
65. May EL: A half century in medicinal chemistry with major emphasis on pain-relieving drugs and their antagonists. J. Med. Chem. 35, 3587-3594 (1992)
66. Mellett LB, Woods LA: Analgesia and addiction. Progress in Drug Res. 5, 156-267 (1963)
67. Michne WF: 2,6-Methano-3-benzazocine-11-propanols. Lack of antagonism between optical antipodes and observation of potent narcotic antagonism by two N-methyl derivatives. J. Med. Chem. 21, 1322-1324 (1978)
68. Mienne WF, Lewis TR, Michalec SJ, Pierson AK, Rosenberg FJ: 2,6-Methano-3-benzazocin-11 betayl)alkanones. 1. Alkylalkanones: a new series of N-methyl derivatives with novel opiate activity profiles. J. Med. Chem. 22, 1158-1163 (1979)
69. Monkovic I, Wong H, Pircio AW, Perron YG, Pachter IJ, Belleau B: Oxilorphan and butorphanol. Potent narcotic antagonists and nonaddicting analgesics in the 3,14-dihydroxymorphinan series. Part VI. Canad. J. Chem. 53, 3094-3102 (1975)
70. Murray A, Hagen NA: Hydromorphone. J. Pain Symptom Manag. 29(5S) S57-S66 (2005)
71. Nagamatsu K, Kido Y, Terao T, Ishida T, Toki S: Effect of morphinone on opiate receptor binding and morphine-elicited analgesia. Life Sci. 31, 1451-1457 (1982)
72. Nagamatsu K, Terao T, Toki S: In vitro formation of codeinone from codeine by rat or guinea pig liver homogenate and its acute toxicity in mice. Biochem. Pharmacol. 34, 3143-3146 (1985)
73. Nagamatsu K, Inoue K, Terao T, Toki S: Effects of glutathione and phenobarbital on the toxicity of codeinone. Biochem. Pharmacol. 35, 1675-1678 (1986)
74. Ong HH, Oh-ishi T, May EL: Phenylmorphan agonists-antagonists. J. Med. Chem. 17, 133-134 (1974)
75. Owen JA, Elliot J, Jhamandas K, Nakatsu K: Morphine diesters. I. Synthesis and action on guinea pig ileum. Can. J. Physiol. Pharmacol. 62, 446-451 (1984)
76. Owen JA, Nakatsu K: Morphine diesters. II. Blood metabolism and analgesic activity in the rat. Can. J. Physiol. Pharmacol. 62, 452-456 (1984)
77. Pachter IJ (1974): Synthetic 14-hydroxymorphinan narcotic antagonists. In: Narcotic Antagonists, eds Braude MC, Harris LS, May EL, Smith JP, Villareal JE, Advances in Biochem. Psychopharmacol. Vol. 8, Raven Press, New York, pp. 57-62
78. Palmer DC, Srauss MJ: Benzomorphans: Synthesis, stereochemistry reactions, and spectroscopic characterizations. Chem. Reviews 77, 1-36 (1977)
79. Pircio AW, Gylys JA: Oxilorphan (1-N-cyclopropylmethyl-3,14-dihydroxy- morphinan): a new synthetic narcotic antagonist. J. Pharmacol. Exp. Ther. 193, 23-34 (1975)
80. Quick J, Herlihy P, Razdan RK, Howes JF: Novel opiates and antagonists. 4. 7-alkanoyl-hydromorphones. J. Med. Chem. 25, 983-986 (1982)
81. Reden J, Reich MF, Rice KC, Jacobson AE, Brossi A, Streaty RA, Klee WA: Deoxymorphines: Role of the phenolic hydroxyl in antinociception and opiate receptor interactions. J. Med. Chem. 22, 256-259 (1979)
82. Robinson FM (1974): Chemistry of narcotic antagonists of the nalorphine type. In: Narcotic Antagonists, eds Braude MC, Harris LS, May EL, Smith JP, Villareal JE, Advances in Biochem. Psychopharmacol. Vol. 8, Raven Press, New York, pp. 21-31
83. Rónai AZ, Foldes FF, Hahn EF, Fishman J: Orientation of the oxygen atom at C-6 as a determinant of agonist activity in the oxymorphone series. J. Pharmacol. Exp. Ther. 200, 496-500 (1977)
84. Sargent LJ, Schwartzman LH, Small L: Hydroxylated codeine derivatives. J. Org. Chem. 23, 1247-1251 (1958)
85. Sargent LJ, May EL: Agonist-antagonists derived from desomorphine and metopon. J. Med. Chem. 13, 1961-1963 (1970)
86. Sawa YK, Irisawa J: Elimination of the 4-hydroxyl group of the alkaloids related to morphine-VII: Synthesis of the active 2′-hydroxy-2-methyl-5,9- diethyl-6,7-benzomorphan derivatives. Tetrahedron 21, 1129-1132 (1965)
87. Sawynok J: The therapeutic use of heroin, a review of the pharmacological literature. Canad. J. Physiol. Pharmacol. 64, 1-6 (1986)
88. Schmidhammer H, Jacobson AE, Atwell L, Brossi A: Structure-activity relationship of oxygenated morphinans. V. Narcotic agonist and antagonist activity in the 14-hydroxy-morphinan series. Preliminary communication. Helv. Chim. Acta 64, 2540-2543 (1981)
89. Schmidhammer H, Jacobson AE, Brossi A: Morphinans and 6-ketomorphinans unsubstituted in the aromatic ring - High analgesic activity of (-)-6-keto-N-methyl-morphinan. 4. Heterocycles 17, 391-394 (1982)
90. Schmidhammer H, Jacobson AE, Brossi A: Chemical and biological study of aromatic oxygenated 6-ketomorphinans. Med. Res. Rev. 3, 1-19 (1983)
91. Schmidhammer H, Aeppli L, Atwell L, Fritsch F, Jacobson AE, Nebuchla M, Sperk G: Synthesis and biological evaluation of 14-alkoxymorphinans. 1. Highly potent opioid agonists in the series of (-)-14-methoxy-N-methylmorphinan-6-ones. J. Med. Chem. 24, 1575-1579 (1984)
92. Schmidhammer H, Deeter JB, Jones ND, Leander JD, Schoepp DD, Schwartzendruber JK: Synthesis, structure elucidation, and pharmacological evaluation of 5-methyl-oxymorphone (= 4,5α-epoxy-3,14-dihydroxy-5,17- dimethylmorphinan-6-one). Helv. Chim. Acta 71, 1801-1804 (1988)
93. Schmidhammer H, Schratz A, Mitterdorfer J: Synthesis and biological evaluation of 14-alkoxymorphinans. Part 8. 14-Methoxymetopon, an extremely potent opioid agonist. Helv. Chim. Acta 73, 1784-1787 (1990)
94. Schmidhammer H, Mayer-Valkanover K, Walla-Kugler M: 5-Methylnaloxone and 5-methylnaltrexone: Synthesis and pharmacological evaluation. Helv. Chim. Acta 73, 1986-1990 (1990)
95. Schmidhammer H: Opioid receptor antagonists. Progress in Med. Chem. 35, 83-132 (1998)
96. Seki I, Takagi H, Kobayashi S: Pharmacological studies on morphine derivatives. I. Pharmacological actions of several normorphines and 14-hydroxynormorphinones. Yakugaku Zasshi 84, 255-267 (1964)
97. Seki I, Takagi H, Kobayashi S, Deguchi T, Kumakura S: Pharmacological studies on morphine derivatives. II. Pharmacological actions of several 14-hydroxy-6-deoxymorphine derivatives. Yakugaku Zasshi 84, 268-279 (1964)
98. Seki I, Takagi H, Kobayashi S: Pharmacological studies on morphine derivatives. III. On the chemical structure-activity relationships of 14-hydroxymorphine derivatives. Yakugaku Zasshi 84, 280-286 (1964)
99. Seki I, Takagi H: Studies ont he morphine alkaloids and related compounds. XVIII. Syntheses of N-substituted-morphinan dihydronormethines and O-alkylisoureas related to morphinan, norpethidine or phenylethylamine. Chem. Pharm. Bull. 18, 1104-1111 (1970)
100. Simon LD, Simon FR, Mohacsi E, Berger EL, Simon EJ: Effects of the position of the phenolic group in morphinans on their affinity for opiate receptor binding. Life Sci. 28, 2769-2772 (1981)
101. Takayanagi I, Konno F, Goromaru N, Koike K, Kanematsu K, Fujii I, Togame H: Some pharmacological properties of a newly synthesized morphine derivative, (-)-6 beta-acetylthiomorphine. Arch. Intern. Pharmacodyn. Ther. 294, 71-84 (1988)
102. Umans JG, Inturrisi CE: Pharmacodynamics of subcutaneously administered diacetylmorphine, 6-acetylmorphine and morphine in mice. J. Pharmacol. Exp. Ther. 218, 409-415 (1981)
103. Umans JG, Inturrisi CE: Heroin: analgesia, toxicity and disposition in the mouse. Eur. J. Pharmacol. 85, 317-323 (1982)
104. Webb JA, Rostami-Hodjegan A, Abdul-Manap R, Hofmann U, Mikus G, Kamali F: Contribution of dihydrocodeine and dihydromorphine to analgesia following dihydrocodeine administration in man: a PK-PD modelling analysis. Br. J. Clin. Pharmacol. 52, 35-43 (2001)
105. Weiss U, Daum SJ: Derivatives of morphine. V. 14-Hydroxymorphine and 14-hydroxydihydromorphine. J. Med. Chem. 8, 123-125 (1965)
106. Winter CA, Orahovats PA, Lehman EG: Analgesic activity and morphine antagonism of compounds related to nalorphine. Arch. Intern. Pharmacodyn. Ther. 110, 186-202 (1957)
107. Wodak A: Managing illicit drug use. A practical guide. Drugs 47, 446-457 (1994)
108. Yeh HJC, Wilson RS, Klee WA, Jacobson AE: α- and β-Halomorphides: Stereochemistry, analgesic potency, toxicity and interaction with narcotic receptors in vitro. J. Pharm. Sci. 65, 902-904 (1976)